一个新的ACVR2A::RAF1融合在螺旋细胞肉瘤
Anfeng Jiang1, Huan Li2,3, Dongbing Li2,3
1Department of Oncology, Xiangya Hospital, Central South University, Changsha, Hunan Province, China.
Genes, chromosomes & cancer
|February 14, 2025
概括
在复发性骨基肉瘤中发现了一种新的ACVR2A::RAF1融合. 针对性治疗Trametinib导致显著的瘤缩和疼痛缓解,证明了分子诊断的价值.
科学领域:
- 在瘤学瘤学.
- 基因组学就是基因组学.
- 分子病理学分子病理学
背景情况:
- 激酶重排的螺旋细胞肉瘤具有不同的分子特征.
- 下一代测序 (NGS) 有助于识别酶融合,用于精确的瘤分类.
研究的目的:
- 报告一个新型ACVR2A::RAF1融合在一个患有复发性底肉瘤的病人.
- 根据分子发现来评估针对性治疗的疗效.
主要方法:
- 瘤组织的组织学和免疫组织化学分析.
- 下一代测序 (NGS) 用于识别遗传改变.
- 使用MEK1抑制剂 (Trametinib) 的治疗.
主要成果:
- 鉴定了一种新型ACVR2A::RAF1融合.
- 用特拉梅替尼布治疗的患者在MRI上显示出显著的瘤缩和疼痛缓解.
- 融合蛋白可能会激活RAF1信号.
结论:
- ACVR2A::RAF1融合是RAF1重新排列状细胞肉瘤的一个新型基因组变异.
- 基于分子诊断的向治疗可以产生显著的临床益处.
- 这一案例强调了分子分析对指导癌症治疗的重要性.
更多相关视频
06:44Author Spotlight: Integrating BRET-Based Assays and Rare Mutation Analysis to Decipher RAF Kinase Regulation in Live Cells
Published on: March 1, 2024
928
09:49Oncogenic Gene Fusion Detection Using Anchored Multiplex Polymerase Chain Reaction Followed by Next Generation Sequencing
Published on: July 5, 2019
9.5K
相关概念视频
Rous Sarcoma Virus (RSV) and Cancer
4.9K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
4.9K
Abnormal Proliferation
4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
The Retinoblastoma Gene
4.0K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.0K
The Ras Gene
6.1K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
6.1K
Cancer Cell Migration through Invadopodia
2.3K
Invadosome is a broad category of cell surface structures with proteolytic activity that degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
2.3K
MAPK Signaling Cascades
5.1K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.1K
